Lanreotide-induced modulation of 5-fluorouracil or mitomycin C cytotoxicity in human colon cancer cell lines: a preclinical study.

about

Lanreotide-induced modulation of 5-fluorouracil or mitomycin C cytotoxicity in human colon cancer cell lines: a preclinical study.

Item

http://www.wikidata.org/entity/Q40835915

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

2000年學術文章

@zh

2000年學術文章

@zh-hant

name

Lanreotide-induced modulation ...... ll lines: a preclinical study.

@en

type

Item

label

Lanreotide-induced modulation ...... ll lines: a preclinical study.

@en

prefLabel

Lanreotide-induced modulation ...... ll lines: a preclinical study.

@en

P1476

Lanreotide-induced modulation ...... ell lines: a preclinical study

@en

P2093

C Casini-Raggi

http://www.w3.org/2001/XMLSchema#string

F Barzanti

http://www.w3.org/2001/XMLSchema#string

F De Paola

http://www.w3.org/2001/XMLSchema#string

G L Frassineti

http://www.w3.org/2001/XMLSchema#string

L Ricotti

http://www.w3.org/2001/XMLSchema#string

W Zoli

http://www.w3.org/2001/XMLSchema#string

P2860

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

New colorimetric cytotoxicity assay for anticancer-drug screening

Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects.

The role of somatostatin and its analogs in the diagnosis and treatment of tumors.

Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.

Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha

A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy.

Somatostatin receptor subtype mRNA expression in human colorectal cancer and normal colonic mucosae.

Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer.

Expression of somatostatin receptors in oncocytic (Hürthle cell) neoplasia of the thyroid

P304

421-430

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1179/JOC.2000.12.5.421

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anna Tesei

P577

2000-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11128563

http://www.w3.org/2001/XMLSchema#string

P921

cytotoxicity